Helmerich & Payne (HP) 74.42 $HP Understanding The

New Post Public Reply Private Reply Replies (0) Message Board

Apr 26, 2015 at 3:10 PM

Helmerich & Payne (HP) 74.42 $HP

Understanding The Benjamin Graham Formula Correctly
Serenity - at Seeking Alpha - Sun Apr 26, 5:28AM CDT
Benjamin Graham - also known as The Dean of Wall Street and The Father of Value Investing - was a scholar and financial analyst who mentored legendary investors such as Warren Buffett, William J. Ruane, Irving Kahn and Walter J. Schloss. Warren...
KGJI: 1.32 (+0.02), UMC: 2.37 (unch), CTCM: 4.24 (-0.18), KBAL: 10.44 (-0.07), HP: 74.42 (-0.91), HFC: 39.76 (+1.26), UVV: 47.78 (+0.05), SCL: 44.55 (+0.39), ATNI: 70.03 (+1.48), RS: 63.14 (+0.45), ROC: 79.20 (+0.33), XIN: 3.44 (-0.08), GPRE: 31.77 (+0.44), FF: 11.18 (+0.03), GNI: 8.10 (+0.67), CSH: 25.94 (-0.03)

Helmerich & Payne - More Pain Is Arriving, Stay Cautious For Now
The Value Investor - at Seeking Alpha - Sat Apr 25, 10:08AM CDT

HP: 74.42 (-0.91)

Shares of HP Up 10.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Apr 24, 4:54PM CDT
SmarTrend identified an Uptrend for Helmerich & Payne (NYSE:HP) on March 20th, 2015 at $67.48. In approximately 1 month, Helmerich & Payne has returned 10.28% as of today's recent price of $74.42.
HP: 74.42 (-0.91)

Helmerich & Payne Investors Should Breathe A Sigh Of Relief
Dan Strack - at Seeking Alpha - Fri Apr 24, 11:28AM CDT

HP: 74.42 (-0.91)

Helmerich & Payne's (HP) CEO John Lindsay on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 23, 10:39PM CDT

HP: 74.42 (-0.91)

Helmerich & Payne (HP) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Thu Apr 23, 5:17PM CDT
The following Helmerich & Payne (HP) conference call took place on April 23, 2015, 11:00 AM ET. This is a transcript of that earnings call:
HP: 74.42 (-0.91)

U.S. Shale Oil: A Grand Parade Of Cost Improvements
Richard Zeits - at Seeking Alpha - Thu Apr 23, 1:26PM CDT

HK: 1.57 (-0.04), HAL: 48.00 (-0.17), SN: 13.58 (-0.05), HP: 74.42 (-0.91), TPLM: 5.51 (+0.08), SLB: 91.61 (-1.44)

Helmerich & Payne Beats Q2 Earnings on Higher Rig Margin - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 11:00AM CDT
Helmerich & Payne Inc. (HP) reported better-than-expected results for the second quarter of fiscal 2015 (three months ended Mar 31, 2015), owing to higher average rig margin per day from the company's U.S. Land Operations unit.
VLP: 49.21 (-0.90), SHLX: 39.16 (+0.70), HP: 74.42 (-0.91), RGP: 22.89 (+0.28)

Helmerich & Payne (HP) Q2 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Apr 23, 9:55AM CDT

HP: 74.42 (-0.91)

Helmerich & Payne (HP) Beats on Q2 Earnings, Revenue - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 6:36AM CDT
Helmerich & Payne (HP) Beats on Q2 Earnings, Revenue
HP: 74.42 (-0.91)

Helmerich & Payne beats Street 2Q forecasts
Automated Insights - Thu Apr 23, 5:24AM CDT
TULSA, Okla. (AP) _ Helmerich & Payne Inc. (HP) on Thursday reported fiscal second-quarter profit of $149.5 million.
HP: 74.42 (-0.91)

Helmerich & Payne EPS of $1.37
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 5:12AM CDT

HP: 74.42 (-0.91)

Helmerich & Payne, Inc. Announces Second Quarter Results
GlobeNewswire - Thu Apr 23, 4:59AM CDT
Helmerich & Payne, Inc. (NYSE:HP) reported net income of $150 million ($1.37 per diluted share) from operating revenues of $883 million for the second fiscal quarter of 2015, compared to net income of $175 million ($1.59 per diluted share) from operating revenues of $893 million during the second quarter of fiscal 2014, and net income of $203 million ($1.85 per diluted share) from operating revenues of $1.06 billion during the first quarter of fiscal 2015. Included in net income per diluted share corresponding to this year's second fiscal quarter are approximately $0.44 of after-tax gains from long-term contract early termination compensation from customers (which favorably impacted net income by approximately $47 million), $0.02 of after-tax gains related to the sale of used drilling equipment, and $0.05 of after-tax losses from abandonment charges related to the decommissioning of the Company's 17 SCR powered FlexRigs(R)*. Included in net income per diluted share corresponding to last year's second fiscal quarter are approximately $0.12 of after-tax gains on the sale of investment securities and $0.02 of after-tax gains related to the sale of used drilling equipment. Included in net income per diluted share corresponding to this year's first fiscal quarter are approximately $0.13 of after-tax gains from long-term contract early termination compensation from customers and $0.02 of after-tax gains related to the sale of used drilling equipment.
HP: 74.42 (-0.91)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 4:30PM CDT

CAM: 52.81 (+0.03), BBT: 37.78 (-0.08), LAZ: 55.89 (-0.32), JAH: 52.23 (-0.97), ASPS: 23.24 (+0.76), HSY: 94.63 (-0.30), CAB: 54.19 (-3.13), CFX: 48.31 (-0.86), FAF: 37.83 (+0.76), HP: 74.42 (-0.91), KKR: 23.39 (-0.15), AEP: 57.88 (+0.98), DNKN: 54.03 (+2.52), CLFD: 14.25 (+0.04), DAN: 21.81 (+0.01), ABBV: 66.07 (+1.82), CSL: 99.55 (+0.47), CAT: 84.60 (-0.19), BHE: 24.30 (-0.16), AVT: 43.47 (-0.28), IR: 68.63 (-0.43), COR: 50.35 (+0.52), ALK: 68.30 (+1.96), COL: 97.79 (-0.16), BKU: 33.10 (-0.29), BCC: 37.41 (-0.29), MJN: 97.94 (+1.53), IQNT: 19.31 (+0.94), ERIC: 11.41 (-0.17), DGX: 75.81 (+0.60), ALXN: 180.08 (-4.50), DOW: 51.12 (+0.12), DST: 118.00 (+0.99), MDP: 53.90 (-0.78), MMM: 158.99 (-0.67), GRA: 97.07 (+0.11), FCX: 20.82 (+0.75), CLI: 18.68 (-0.03), DHR: 83.30 (-1.39), FNB: 13.12 (-0.07), LUV: 43.49 (+0.23), DPS: 78.86 (-0.09), IVC: 20.68 (+0.14), GMT: 55.80 (+0.15), JNS: 18.51 (unch), DPZ: 113.96 (+4.73), DLX: 67.37 (-0.17), CMS: 35.16 (+0.15), LTM: 71.46 (+0.02), MDSO: 57.59 (+0.05), LLY: 71.58 (-0.82), BMS: 45.56 (+0.84), EQT: 86.59 (-0.95), MHO: 23.59 (+0.38), BTU: 4.49 (-0.01), GPK: 14.74 (+0.01), BAX: 71.14 (-0.37), EQM: 88.01 (+0.87), BEAV: 61.60 (-0.64), GM: 35.59 (-0.33), HUB.B: 109.32 (-1.00), JCI: 52.48 (-0.42)

Helmerich & Payne Falls 2.67% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Apr 21, 5:07PM CDT
Helmerich & Payne (NYSE:HP) traded in a range yesterday that spanned from a low of $71.68 to a high of $74.71. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $73.25 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HP: 74.42 (-0.91)

Helmerich & Payne (HP) Q2 Earnings: What to Expect? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 11:10AM CDT
Helmerich & Payne Inc. (HP) is expected to release its fiscal second-quarter 2015 results before the opening bell on Thursday, Apr 23. Our proven model does not conclusively show that Helmerich & Payne is likely to beat earnings this quarter.
SU: 33.06 (+0.08), WLL: 35.62 (-1.01), HP: 74.42 (-0.91), CVE: 19.16 (-0.11)

6 Best Champion Dividend Dogs Show 8% To 11.4% April Upsides, 4 Drop 7% To 14%
Fredrik Arnold - at Seeking Alpha - Sun Apr 19, 1:09AM CDT

WGL: 57.40 (+0.74), KO: 40.89 (-0.06), STR: 24.19 (+0.07), HCP: 42.45 (-0.12), UHT: 53.29 (+0.23), ED: 62.50 (+0.40), SYY: 37.93 (-0.02), NNN: 41.04 (-0.13), CTBI: 32.91 (+0.02), HP: 74.42 (-0.91), MO: 52.07 (-0.28), UVV: 47.78 (+0.05), T: 34.01 (-0.22), NWN: 48.70 (+0.43), MCY: 58.30 (-0.16), CVX: 109.87 (-0.10), BKH: 51.09 (+0.42), ORI: 15.59 (+0.22)

The Best Stocks to Invest in Oil Rigs
Tyler Crowe, The Motley Fool - Motley Fool - Fri Apr 17, 7:03AM CDT
Image Source: U.S. Bureau of Land Management. There are any ways to invest in the oil and gas space. You can go for massive companies such as ExxonMobil that have a finger in every aspect of the oil and gas value chain, or you can target one...
SDLP: 13.03 (+0.03), XOM: 86.97 (-0.57), HP: 74.42 (-0.91), SDRL: 11.39 (-0.26)

Offshore drillers sink as Aramco secures lower Ensco rates
Seeking Alpha - at Seeking Alpha - Thu Apr 16, 9:58AM CDT

PACD: 4.31 (-0.03), HERO: 0.71 (+0.02), DO: 29.82 (-0.58), RIG: 16.40 (-0.57), ESV: 24.04 (-0.23), ORIG: 6.87 (-0.11), HP: 74.42 (-0.91), SDRL: 11.39 (-0.26), ATW: 28.74 (-0.95), RDC: 19.26 (-0.28), NE: 15.67 (-0.40)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...